Athersys Inc (NASDAQ: ATHX) announced that the peer-reviewed periodical Scientific Reports printed statistics accrued from numerous years of the preclinical investigation. The journal defines the results from widespread in vitro readings The journal defines the conclusions from all-embracing in vitro training examining the role Multipotent Adult Progenitor Cells (MAPC®), clinically […]